WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

Abridge inks deals with Nvidia and Lilly

Abridge announced new deals with Eli Lilly and Nvidia as it aims to gain an edge in a competitive market.

Raccontata dafiercehealthcare.comstatnews.comfortune.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
statnews.comStai leggendo5 h fa

Abridge inks deals with Nvidia and Lilly

Abridge secures strategic investment from Eli Lilly and Nvidia partnership to develop purpose-built foundation model for clinical conversations. Specialized domain models replace generic AI as market requirement for competitive enterprise healthcare adoption.

originale
fiercehealthcare.com5 h fa

Abridge picks up strategic investment from Eli Lilly, expands payer, research workflows

Since launching eight years ago with an ambient medical transcription tool, Abridge has set is sights more broadly on building out a full-scale AI clinical assistant. | Abridge secured a strategic investment from Eli…

Leggi questa versione →

Timeline cronologica

  1. giovedì 11 giugno 2026·fiercehealthcare.com

    Abridge picks up strategic investment from Eli Lilly, expands payer, research workflows

    Since launching eight years ago with an ambient medical transcription tool, Abridge has set is sights more broadly on building out a full-scale AI clinical assistant. | Abridge…

  2. giovedì 11 giugno 2026·statnews.com

    Abridge inks deals with Nvidia and Lilly

    Abridge announced new deals with Eli Lilly and Nvidia as it aims to gain an edge in a competitive market.

originale
fortune.com4 h fa

Abridge wants to be the operating system for medicine—and NVIDIA and Eli Lilly are helping build it | Fortune

Abridge ($5.3B Series E, NVIDIA/Eli Lilly) scaled ambient AI from transcription into clinical decisions, billing, and trial screening across 300+ systems. Platform creates moat connecting providers-payers-pharma via PHI, but risks mount as AI notes become permanent records.

Leggi questa versione → originale
  • giovedì 11 giugno 2026·fortune.com

    Abridge wants to be the operating system for medicine—and NVIDIA and Eli Lilly are helping build it | Fortune

    The $5.3 billion ambient AI startup is expanding from clinical notes into billing, drug trials, and real-time insurance claims.